Relocation of Orbitrap Fusion and Q-Exactive LC-MS Systems and perform post-move preventative maintenance (PM) and IQ/OQ for these systems and performance verification.
Closed Solicitation Posted
- Solicitation number
- FDA-RFQ-CDER-2022-112632
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- Saint Louis, Missouri 63110, United States
Notice details come from SAM.gov. Updated .
Notice text
The U. S. Food & Drug Administration, (FDA) Office of Acquisition and Grants Services (OAGS) has a requirement for the Relocation of Orbitrap Fusion and Q-Exactive LC-MS Systems and perform post-move preventative maintenance (PM) and IQ/OQ for these systems and performance verification.
Files
| File | Type | Posted |
|---|---|---|
| FDA-RFQ-CDER-2022-112632-Relocation of Orbitrap Fusion and Q-Exactive LC-MS Systems and PMA .docx | DOCX document |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity